Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Good in vitro activity reported for Novartis PKC inhibitor

Jan. 12, 1998

Merck continues to devote extensive R&D efforts to FTase inhibitors

Jan. 12, 1998

New phosphatase inhibitors from the University of Pittsburgh

Jan. 9, 1998

New rationale elucidated for clinical evaluation of GW-506U in refractory hematologic malignancies

Jan. 9, 1998

New vitamin D conjugates disclosed by Clarion

Jan. 8, 1998

Protein farnesyltransferase inhibitors disclosed by Schering-Plough

Jan. 8, 1998

Photofrin approval sought in nine additional European countries

Jan. 7, 1998

Theratechnologies to begin clinical testing of leukemia Rx

Jan. 7, 1998

More on peptidomimetic protein farnesyltransferase inhibitors from Merck & Co.

Jan. 7, 1998

MMP inhibitor developed at Chiroscience enters clinical trials for cancer

Jan. 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...